Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 2

Natalizumab for the treatment of relapsing multiple sclerosis

Total article views   HTML views PDF downloads Totals
7,937 Dovepress* 7,937+ 2,547 10,484
Totals 7,937 2,547 10,484
*Since 6 June 2008
+Since July 2016

View citations on Google Scholar